Russell Investments Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-574
| Closed | -$16.6K | – | 3749 |
|
|
2024
Q2 | $16.6K | Buy |
574
+403
| +236% | +$11.7K | ﹤0.01% | 2972 |
|
|
2024
Q1 | $7.62K | Buy |
+171
| New | +$7.62K | ﹤0.01% | 2884 |
|
|
2023
Q3 | – | Sell |
-1,065
| Closed | -$67.7K | – | 3583 |
|
|
2023
Q2 | $67.7K | Sell |
1,065
-2,472
| -70% | -$157K | ﹤0.01% | 2676 |
|
|
2023
Q1 | $167K | Buy |
+3,537
| New | +$167K | ﹤0.01% | 2506 |
|